Peer victimization in middle childhood impedes adaptive responses to stress: a pathway to depressive symptoms.

Peer victimization in middle childhood impedes adaptive responses to stress: a pathway to depressive symptoms.
复制标题

DOI:
10.1080/15374416.2014.891225
复制
发表时间:
2015
期刊:
Journal of clinical child and adolescent psychology : the official journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53
影响因子:
--
通讯作者:
Little TD
Little TD
中科院分区:
其他
文献类型:
--
作者:
Troop-Gordon W;Rudolph KD;Sugimura N;Little TD

文献摘要

被引文献

相似文献

虽然童年时期的同伴伤害与后来的精神病理学之间的关联有很好的记录,但令人惊讶的是,很少有研究直接研究这些持久影响的途径。本研究探讨这一问题,通过检查是否适应不良的反应,同伴攻击(不太努力的参与应对和更多的非自愿反应)调解同伴受害和后来的抑郁症状之间的关联。从三年级开始,连续三年收集了636名儿童(338名女孩,298名男孩; M =8.94岁,SD = 0.37)的数据。研究结果支持这一命题,即同伴受害预测较低水平的努力参与应对和较高水平的非自愿参与和脱离压力的反应。此外,这些对压力的反应有助于解释三年级同伴受害和五年级抑郁症状之间的联系。在这些联系中没有出现性别差异。这些发现建立在先前的理论和研究的基础上,对同伴受害如何以及为什么成为抑郁症状的早期风险因素提供了更细致的理解。
Although associations between peer victimization in childhood and later psychopathology are well documented, surprisingly little research directly examines pathways accounting for these enduring effects. The present study addresses this issue by examining whether maladaptive responses to peer aggression (less effortful engagement coping and more involuntary responses) mediate associations between peer victimization and later depressive symptoms. Data were collected on 636 children (338 girls, 298 boys; M =8.94 years, SD =.37) for three consecutive years beginning in 3rd grade. Findings supported the proposition that peer victimization predicts lower levels of effortful engagement coping and higher levels of involuntary engagement and disengagement responses to stress. Moreover, these responses to stress helped to explain the link between 3rd-grade peer victimization and 5th-grade depressive symptoms. No sex differences in these linkages emerged. These findings build on prior theory and research by providing a more nuanced understanding of how and why peer victimization serves as an early risk factor for depressive symptoms.